NEOGEN CORP(NASDAQ:NEOG) stock Fundamental Analysis

Fundamental Rating

We assign a fundamental rating of 4 out of 10 to NEOG. NEOG was compared to 189 industry peers in the Health Care Equipment & Supplies industry. Both the profitability and the financial health of NEOG get a neutral evaluation. Nothing too spectacular is happening here. NEOG is valued correctly, but it does not seem to be growing.

Quickly go to:

1. Profitability

1.1 Basic Checks

In the past year NEOG was profitable.

In the past year NEOG had a positive cash flow from operations.

In multiple years NEOG reported negative net income over the last 5 years.

In the past 5 years NEOG always reported a positive cash flow from operatings.

1.2 Ratios

NEOG's Return On Assets of -12.02% is in line compared to the rest of the industry. NEOG outperforms 59.26% of its industry peers.

With a decent Return On Equity value of -18.24%, NEOG is doing good in the industry, outperforming 62.96% of the companies in the same industry.

NEOG's Return On Invested Capital of 0.50% is fine compared to the rest of the industry. NEOG outperforms 66.67% of its industry peers.

NEOG had an Average Return On Invested Capital over the past 3 years of 2.71%. This is significantly below the industry average of 7.87%.

		Industry Rank	Sector Rank
ROA	-12.02%
ROE	-18.24%
ROIC	0.5%

ROA(3y)1.38%

ROA(5y)3.65%

ROE(3y)1.47%

ROE(5y)3.97%

ROIC(3y)2.71%

ROIC(5y)4.4%

1.3 Margins

NEOG has a better Operating Margin (2.72%) than 68.25% of its industry peers.

In the last couple of years the Operating Margin of NEOG has declined.

With a Gross Margin value of 48.79%, NEOG perfoms like the industry average, outperforming 41.80% of the companies in the same industry.

In the last couple of years the Gross Margin of NEOG has grown nicely.

		Industry Rank	Sector Rank
OM	2.72%
PM (TTM)	N/A
GM	48.79%

OM growth 3Y-20.27%

OM growth 5Y-13.36%

PM growth 3YN/A

PM growth 5YN/A

GM growth 3Y3.02%

GM growth 5Y1.61%

More info and screens

ROA

ROE

ROIC

Operating and Profit Margin

Show most profitable peers

2. Health

2.1 Basic Checks

NEOG has a Return on Invested Capital (ROIC), which is below the Cost of Capital (WACC), which means it is destroying value.

NEOG has about the same amout of shares outstanding than it did 1 year ago.

Compared to 5 years ago, NEOG has more shares outstanding

NEOG has a worse debt/assets ratio than last year.

2.2 Solvency

Based on the Altman-Z score of 0.98, we must say that NEOG is in the distress zone and has some risk of bankruptcy.

The Altman-Z score of NEOG (0.98) is comparable to the rest of the industry.

NEOG has a Debt/Equity ratio of 0.33. This is a healthy value indicating a solid balance between debt and equity.

NEOG's Debt to Equity ratio of 0.33 is in line compared to the rest of the industry. NEOG outperforms 48.68% of its industry peers.

		Industry Rank	Sector Rank
Debt/Equity	0.33
Debt/FCF	N/A
Altman-Z	0.98

ROIC/WACC0.06

WACC8.08%

2.3 Liquidity

A Current Ratio of 3.91 indicates that NEOG has no problem at all paying its short term obligations.

With a decent Current ratio value of 3.91, NEOG is doing good in the industry, outperforming 63.49% of the companies in the same industry.

A Quick Ratio of 2.45 indicates that NEOG has no problem at all paying its short term obligations.

With a Quick ratio value of 2.45, NEOG perfoms like the industry average, outperforming 56.61% of the companies in the same industry.

		Industry Rank	Sector Rank
Current Ratio	3.91
Quick Ratio	2.45

More info and screens

WACC

Debt/Equity

How to determine the health of a company

Altman-Z score

Show peers with great health

3. Growth

3.1 Past

NEOG shows a strong negative growth in Earnings Per Share. In the last year the EPS decreased by -20.83%.

Measured over the past years, NEOG shows a decrease in Earnings Per Share. The EPS has been decreasing by -5.21% on average per year.

NEOG shows a decrease in Revenue. In the last year, the revenue decreased by -2.50%.

Measured over the past years, NEOG shows a quite strong growth in Revenue. The Revenue has been growing by 17.41% on average per year.

EPS 1Y (TTM)-20.83%

EPS 3Y-8.53%

EPS 5Y-5.21%

EPS Q2Q%-16.67%

Revenue 1Y (TTM)-2.5%

Revenue growth 3Y25.42%

Revenue growth 5Y17.41%

Sales Q2Q%-3.42%

3.2 Future

The Earnings Per Share is expected to grow by 6.10% on average over the next years.

NEOG is expected to show a small growth in Revenue. In the coming years, the Revenue will grow by 1.81% yearly.

EPS Next Y-14.23%

EPS Next 2Y-3.7%

EPS Next 3Y2.16%

EPS Next 5Y6.1%

Revenue Next Year-2.43%

Revenue Next 2Y-0.98%

Revenue Next 3Y0.13%

Revenue Next 5Y1.81%

3.3 Evolution

When comparing the EPS growth rate of the last years to the growth rate of the upcoming years, we see that the growth is accelerating.

The Revenue growth rate is decreasing: in the next years the growth will be less than in the last years.

More info and screens

Find the best growth stocks

Show best growing peers

4. Valuation

4.1 Price/Earnings Ratio

NEOG is valuated correctly with a Price/Earnings ratio of 16.37.

83.07% of the companies in the same industry are more expensive than NEOG, based on the Price/Earnings ratio.

The average S&P500 Price/Earnings ratio is at 26.03. NEOG is valued slightly cheaper when compared to this.

With a Price/Forward Earnings ratio of 15.25, NEOG is valued correctly.

Based on the Price/Forward Earnings ratio, NEOG is valued cheaper than 83.60% of the companies in the same industry.

NEOG's Price/Forward Earnings ratio indicates a valuation a bit cheaper than the S&P500 average which is at 21.94.

		Industry Rank	Sector Rank
PE	16.37
Fwd PE	15.25

4.2 Price Multiples

Based on the Enterprise Value to EBITDA ratio, NEOG is valued cheaper than 80.42% of the companies in the same industry.

		Industry Rank	Sector Rank
P/FCF	N/A
EV/EBITDA	14.79

4.3 Compensation for Growth

PEG (NY)N/A

PEG (5Y)N/A

EPS Next 2Y-3.7%

EPS Next 3Y2.16%

More info and screens

Show best valued peers

5. Dividend

5.1 Amount

NEOG does not give a dividend.

		Industry Rank	Sector Rank
Dividend Yield	N/A

More info and screens

Find the best dividend stocks

Show peers with best dividend

NEOGEN CORP

NASDAQ:NEOG (5/21/2025, 8:21:22 PM)

After market: 6.09 -0.13 (-2.09%)

6.22

+0.02 (+0.32%)

Chartmill FA Rating

GICS SectorHealth Care

GICS IndustryGroupHealth Care Equipment & Services

GICS IndustryHealth Care Equipment & Supplies

Earnings (Last)04-09 2025-04-09/bmo

Earnings (Next)07-28 2025-07-28/amc

Inst Owners121.73%

Inst Owner Change6.46%

Ins Owners0.23%

Ins Owner Change22.56%

Market Cap1.35B

Analysts82

Price Target8.67 (39.39%)

Short Float %12.57%

Short Ratio3.91

Dividend

		Industry Rank	Sector Rank
Dividend Yield	N/A

Yearly DividendN/A

Dividend Growth(5Y)N/A

DPN/A

Div Incr Years0

Div Non Decr Years0

Ex-DateN/A

Surprises & Revisions

EPS beat(2)1

Avg EPS beat(2)0.34%

Min EPS beat(2)-10.87%

Max EPS beat(2)11.56%

EPS beat(4)1

Avg EPS beat(4)-8.33%

Min EPS beat(4)-19.26%

Max EPS beat(4)11.56%

EPS beat(8)2

Avg EPS beat(8)50.77%

EPS beat(12)4

Avg EPS beat(12)43.66%

EPS beat(16)4

Avg EPS beat(16)25.09%

Revenue beat(2)0

Avg Revenue beat(2)-1.93%

Min Revenue beat(2)-3.66%

Max Revenue beat(2)-0.19%

Revenue beat(4)1

Avg Revenue beat(4)-0.54%

Min Revenue beat(4)-3.66%

Max Revenue beat(4)2.8%

Revenue beat(8)2

Avg Revenue beat(8)-0.83%

Revenue beat(12)2

Avg Revenue beat(12)-1.27%

Revenue beat(16)4

Avg Revenue beat(16)-0.85%

PT rev (1m)-42.05%

PT rev (3m)-42.05%

EPS NQ rev (1m)0%

EPS NQ rev (3m)-30.77%

EPS NY rev (1m)0%

EPS NY rev (3m)-11.9%

Revenue NQ rev (1m)-0.04%

Revenue NQ rev (3m)-6.42%

Revenue NY rev (1m)-1.08%

Revenue NY rev (3m)-2.1%

Valuation

		Industry Rank	Sector Rank
PE	16.37
Fwd PE	15.25
P/S	1.49
P/FCF	N/A
P/OCF	19.72
P/B	0.51
P/tB	N/A
EV/EBITDA	14.79

EPS(TTM)0.38

EY6.11%

EPS(NY)0.41

Fwd EY6.56%

FCF(TTM)-0.2

FCFYN/A

OCF(TTM)0.32

OCFY5.07%

SpS4.17

BVpS12.26

TBVpS-2.08

PEG (NY)N/A

PEG (5Y)N/A

Profitability

		Industry Rank	Sector Rank
ROA	-12.02%
ROE	-18.24%
ROCE	0.63%
ROIC	0.5%
ROICexc	0.52%
ROICexgc	2.96%
OM	2.72%
PM (TTM)	N/A
GM	48.79%
FCFM	N/A

ROA(3y)1.38%

ROA(5y)3.65%

ROE(3y)1.47%

ROE(5y)3.97%

ROIC(3y)2.71%

ROIC(5y)4.4%

ROICexc(3y)3.97%

ROICexc(5y)7.43%

ROICexgc(3y)14.92%

ROICexgc(5y)18.11%

ROCE(3y)3.43%

ROCE(5y)5.58%

ROICexcg growth 3Y-23.14%

ROICexcg growth 5Y-16.2%

ROICexc growth 3Y-51.38%

ROICexc growth 5Y-36.83%

OM growth 3Y-20.27%

OM growth 5Y-13.36%

PM growth 3YN/A

PM growth 5YN/A

GM growth 3Y3.02%

GM growth 5Y1.61%

F-Score4

Asset Turnover0.22

Health

		Industry Rank	Sector Rank
Debt/Equity	0.33
Debt/FCF	N/A
Debt/EBITDA	6.24
Cap/Depr	95.45%
Cap/Sales	12.44%
Interest Coverage	250
Cash Conversion	47.97%
Profit Quality	N/A
Current Ratio	3.91
Quick Ratio	2.45
Altman-Z	0.98

F-Score4

WACC8.08%

ROIC/WACC0.06

Cap/Depr(3y)91%

Cap/Depr(5y)106.13%

Cap/Sales(3y)8.23%

Cap/Sales(5y)7.23%

Profit Quality(3y)N/A

Profit Quality(5y)N/A

High Growth Momentum

Growth

EPS 1Y (TTM)-20.83%

EPS 3Y-8.53%

EPS 5Y-5.21%

EPS Q2Q%-16.67%

EPS Next Y-14.23%

EPS Next 2Y-3.7%

EPS Next 3Y2.16%

EPS Next 5Y6.1%

Revenue 1Y (TTM)-2.5%

Revenue growth 3Y25.42%

Revenue growth 5Y17.41%

Sales Q2Q%-3.42%

Revenue Next Year-2.43%

Revenue Next 2Y-0.98%

Revenue Next 3Y0.13%

Revenue Next 5Y1.81%

EBIT growth 1Y-66.32%

EBIT growth 3Y-0.01%

EBIT growth 5Y1.73%

EBIT Next Year62.88%

EBIT Next 3Y24.17%

EBIT Next 5Y15.27%

FCF growth 1Y46.24%

FCF growth 3YN/A

FCF growth 5YN/A

OCF growth 1Y331.64%

OCF growth 3Y-24.24%

OCF growth 5Y-11.19%

NEOGEN CORP (NEOG) Stock Fundamental Analysis

1. Profitability

1.1 Basic Checks

1.2 Ratios

1.3 Margins

More info and screens

2. Health

2.1 Basic Checks

2.2 Solvency

2.3 Liquidity

More info and screens

3. Growth

3.1 Past

3.2 Future

3.3 Evolution

More info and screens

4. Valuation

4.1 Price/Earnings Ratio

4.2 Price Multiples

4.3 Compensation for Growth

More info and screens

5. Dividend

5.1 Amount

More info and screens